← All companies

BDTX

Black Diamond Therapeutics, Inc.

BDTX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.74

+0.02 +1.17%

Key statistics

from XBRL data in SEC filings

Market cap

$99.4M

Revenue (TTM)

$0.00

Net income (TTM)

$22.3B

EPS (TTM)

$-0.75

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$30.1M

Total assets

$133M

Gross margin

—

52-week range

$1.60 – $4.94

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 29, 2026 8-K Regulation FD disclosure; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Mar 16, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Oct 7, 2024 8-K Regulation FD disclosure; Other events Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change; Regulation FD disclosure Apr 11, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Director or officer change Jan 18, 2024 8-K Regulation FD disclosure Jan 4, 2024 8-K Regulation FD disclosure; Other events Dec 13, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 6, 2023 8-K Director or officer change; Regulation FD disclosure Sep 18, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Results of operations (earnings release) Aug 11, 2023 8-K Entered a material agreement Jun 30, 2023 8-K Regulation FD disclosure; Other events Jun 27, 2023 8-K Shareholder vote results May 16, 2023